| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |